|
|
Autism Speaks, Science, Latest Research
Memantine Study to Target Motor Dysfunction in Autism. Cure Autism Now Kicks Off Recruitment for its First Clinical Trials Network Study ...
"Memantine Study" from Glaucoma Associates of Texas
Glaucoma Associates of Texas: comprehensive glaucoma physicians who provide the highest quality of glaucoma care, both surgically and medically. A team approach ...
memantine.com - Study overview
Study overview. References. Results of Memantine Therapy. Gauthier et al. 2005 ... Memantine is now available in the USA. For more information, please visit ...
memantine.com - Clincial Studies
Clincial Studies. Clinical studies with memantine show ... Combination Therapy with Memantine. Memantine Study Overview В© 2009 Merz. All Rights Reserved. ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... In vitro studies have shown that memantine does not affect the reversible ...
Memantine
Memantine Given to Wernicki-Korsakoff: In a 16 patient DB PC ... A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. ...
FDA Approves Alzheimer's Drug
The entry page to Global Action on Aging's Web site. ... The unpublished study showed that patients getting both Memantine and an older ...
Baltimore Huntington's Disease Center
The Johns Hopkins Radiosurgery Group includes radiosurgery specialists committed to ... However, the FDA has approved the use of Memantine in this study. ...
Buy Memantine (Ebixa) - Optimal Health Products
Some studies indicate that Ebixa could be effective for Parkinson's ... Furthermore, the study stated that; "Memantine was devoid of concerning side effects. ...
NRM: Waiting for memantine
A European Phase III memantine study released its preliminary results simultaneously. ... In this prospective study, the memantine treatment group saw statistically ...
|
|
|
|
Memantine study |
Forest Laboratories, Inc. Announces Positive Results of Memantine
Study of Once-Daily Formulation - Drugs.com MedNews
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
NEW YORK, February 05, 2008 /PRNewswire-FirstCall/ -- Forest
Laboratories, Inc. today announced preliminary results of a Phase
III study of memantine HCl (currently marketed as Namenda(R), a
twice-daily immediate- release formulation) in a novel once-daily
formulation. The study evaluated the efficacy, safety, and
tolerability of an innovative, proprietary, 28 mg memantine
extended-release, once-daily formulation compared to placebo in
outpatients with moderate to severe Alzheimer's disease currently
treated with a cholinesterase inhibitor. The results indicate that
patients treated with memantine 28 mg extended-release formulation
experienced statistically significant benefits in cognition and
clinical global status compared to placebo. Additional data from
the study are expected to be presented later in the year.
|
Rating: 3.5 из 5 (голосов: 151) |
|
21 february 2008
Шура Чебурекин
|
|
|
|
|
effect of memantine
a memantine
of action of memantine
and memantine in
|
|
|
|
|
CATIE-AD: Atypical Antipsychotics Linked to Weight Gain in Older Women
Medscape - Apr 23, 2009
At randomization, 46% were using antihypertensive agents, 60% were taking a cholinesterase inhibitor or memantine, 24% were on cholesterol-lowering ...
Forest Laboratories, Inc Q1 2009 Earnings Call Transcript
Seeking Alpha - Apr 21, 2009
The NDA for memantine ER is completed and waiting in the wings as we continue to monitor the patent litigation activities around Namenda. ...
FRX
Non-drug Treatment Of Alzheimer's Disease? Long-term Benefit Not ...
Science Daily (press release) - Apr 15, 2009
None of the 33 studies compared a non-drug intervention with a drug intervention assessed by IQWiG (cholinesterase inhibitors, ginkgo compounds, memantine). ...
Big Idea, Small Detail: Health, Money and Work
Reader's Digest - Apr 14, 2009
Multiyear studies at Harvard University and the University of Pittsburgh show that the drug memantine may have a valuable role in treating the disease. ...
Forest Under Fire
Psychiatric Times - Apr 8, 2009
The complaint also accused Forest of deceiving physicians by promoting the results of a positive study on pediatric use of citalopram,1 while failing to ...
FRX
Is Big Food the next Big Tobacco?
6minutes - Apr 15, 2009
Similarly memantine in dementia is just a minor tweak on the old drug amantadine, and there are no studies ion low glutamate diets in dementia. ...
|
|
|
|
|